Antitumor efficacy of conventional anticancer drugs is enhanced by the vascular targeting agent ZD6126

This publication has 31 references indexed in Scilit:

• Antitumor Effects due to Irreversible Stoppage of Tumor Tissue Blood Flow: Evaluation of a Novel Combretastatin A-4 Derivative, AC7700
  Japanese Journal of Cancer Research, 1999
• Enhancement of tumor radiation response by the antivascular agent 5,6-dimethylxanthenone-4-acetic acid
  International Journal of Radiation Oncology*Biology*Physics, 1998
• Radiobiological Hypoxia in the KHT Sarcoma: Predictions Using the Eppendorf Histograph
  International Journal of Radiation Oncology*Biology*Physics, 1998
• Clinical Applications of Research on Angiogenesis
  New England Journal of Medicine, 1995
• Anti—vascular approaches to solid tumour therapy: Evaluation of vinblastine and flavone acetic acid
  International Journal of Cancer, 1995
• Induction of tumour necrosis factor-? by single and repeated doses of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid
  Cancer Chemotherapy and Pharmacology, 1995
• Combining bioreductive drugs (SR 4233 or SN 23862) with the vasoactive agents flavone acetic acid or 5,6-dimethylxanthenone acetic acid
  International Journal of Radiation Oncology*Biology*Physics, 1994
• Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy
  The British Journal of Radiology, 1993
• Potential antitumor agents. 61. Structure-activity relationships for in vivo colon 38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids
  Journal of Medicinal Chemistry, 1991
• Potentiation of combination chemotherapy by nitroheterocyclics
  International Journal of Radiation Oncology*Biology*Physics, 1988